Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
sifalimumab | interferon alpha-2 | biotech | NA | drugbank | Renal Cell Carcinoma[MeSHID:D002292] Lupus Erythematosus Systemic[MeSHID:D008180] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | investigational | unknown |
sifalimumab | interferon alpha/beta receptor 2 | NA | Successful target | TTD , DGIDB | Renal Cell Carcinoma[MeSHID:D002292] Lupus Erythematosus Systemic[MeSHID:D008180] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
2.65 | approved | unknown |
click here to return to the previous page |